Xconomy

GBT Receives Rare Impact Award for Innovation from the National Organization of Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) Tablets

Retrieved on: 
Monday, October 12, 2020

GBT received the award for Oxbryta (voxelotor) tablets at a virtual event on October 9, 2020, following NORDs annual Rare Disease and Orphan Products Breakthrough Summit.

Key Points: 
  • GBT received the award for Oxbryta (voxelotor) tablets at a virtual event on October 9, 2020, following NORDs annual Rare Disease and Orphan Products Breakthrough Summit.
  • The NORD Rare Impact Awards celebrate the individuals, groups, and companies making extraordinary contributions to the lives of rare disease patients and caregivers.
  • In addition, on September 24, 2020, Oxbryta was selected by the 2020 National Xconomy Awards as Breakthrough Drug of the Year .
  • Each year, the National Xconomy Awards honor the top individuals, companies, and organizations within the United States life sciences ecosystem.

Athena CEO Holly Smithson Awarded Business Woman of the Year

Retrieved on: 
Friday, November 15, 2019

SAN DIEGO, Nov. 15, 2019 /PRNewswire-PRWeb/ -- Athena announces that its Chief Executive Officer, Holly Smithson is awarded San Diego Business Journal (SDBJ) Business Woman of the Year for 2019.

Key Points: 
  • SAN DIEGO, Nov. 15, 2019 /PRNewswire-PRWeb/ -- Athena announces that its Chief Executive Officer, Holly Smithson is awarded San Diego Business Journal (SDBJ) Business Woman of the Year for 2019.
  • The SDBJ annually recognizes San Diego business leaders contributing with distinction to their workplaces and communities.
  • Prior to joining Athena as CEO in 2017, Smithson served as Vice President, Business Strategy at the California Life Sciences Association, the nation's largest statewide advocacy organization for the life sciences sector.
  • She has been recognized by multiple organizations, including San Diego Business Journal (CEO of the Year, 2019), Xconomy (Diversity Champion Finalist, 2019), San Diego Magazine (Woman of the Year Finalist, 2019).

Openwater Prepares to Build Developer Kits

Retrieved on: 
Tuesday, May 8, 2018

After demonstrating a prototype working system at TED, Openwater announced today that it is ramping up to build developer kits.

Key Points: 
  • After demonstrating a prototype working system at TED, Openwater announced today that it is ramping up to build developer kits.
  • "These should enable new generations of non-invasive diagnoses and treatments, and even brain-to-computer communications without cracking open our skulls."
  • Excel's investments include Aileron, ClearDATA, Gemphire, InfoBionic, Molecular Templates, Oculus, Openwater, Orionis, QStream, Saladax, Synthetic Genomics, Virgin Pulse, Tetraphase, WellDoc, and Zipongo.
  • IEEE Spectrum "Why Mary Lou Jepsen left Facebook: to transform healthcare and consumer telepathy" 3/15/17
    Xconomy "Mary Lou Jepsen on life post-Facebook and New Startup, Openwater" 5/6/16